Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences

Conclusion: 18F-FET PET may add valuable information for treatment monitoring in BM patients treated with ICI or TT.

Source: Journal of Nuclear Medicine - March 29, 2021 Category: Nuclear Medicine Authors: Galldiks, N., Abdulla, D. S. Y., Scheffler, M., Wolpert, F., Werner, J.-M., Hullner, M., Stoffels, G., Schweinsberg, V., Schlaak, M., Kreuzberg, N., Landsberg, J., Lohmann, P., Ceccon, G., Baues, C., Trommer, M., Celik, E., Ruge, M. I., Kocher, M., Marnit Tags: Clinical Source Type: research